# Early Vasopressors in Sepsis

> **NCT05179499** · PHASE3 · RECRUITING · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 1006 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Norepinephrine
- **OTHER:** Balanced Crystalloid

## Key facts

- **NCT ID:** NCT05179499
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-11
- **Primary completion:** 2026-11
- **Final completion:** 2027-10
- **Target enrollment:** 1006 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05179499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05179499, "Early Vasopressors in Sepsis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05179499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*